Actinium Pharmaceuticals to Present at the BioCentury 23rd Annual NewsMakers in the Biotech Industry Conference Aug 23, 2016
Actinium Pharmaceuticals Granted SME Status by the European Medicines Agency; Reiterates Focus on EU Market Aug 9, 2016
Actinium Pharmaceuticals Issues Mid-Year Letter to Shareholders Providing Update on Company Progress and Anticipated Milestones Aug 4, 2016
Actinium Pharmaceuticals Highlights Successful Investigator Meeting for Pivotal Phase 3 Iomab-B SIERRA Trial Jul 20, 2016
Actinium Receives Assignment of Intellectual Property From Memorial Sloan Kettering Cancer Center Specific to Actinium's APIT Platform and the Use of Actinium-225 Jul 12, 2016
Actinium Pharmaceuticals to Sponsor Investigator Meeting for Pivotal Phase 3 SIERRA Trial for Iomab-B Jul 6, 2016
Actinium Sponsored Acute Myeloid Leukemia (AML) Awareness Month to Feature Webinar Focused on Transplantation as a Treatment Option for Blood Cancers Jun 28, 2016
